Werewolf Therapeutics Inc (HOWL) — Financial Flexibility Index
Werewolf Therapeutics Inc (HOWL) has a Financial Flexibility Index of 0.84x as of June 2026. Free cash flow of $6.63 Million (operating CF $6.63 Million minus capex $0.00) represents 1% of total liabilities ($7.86 Million). Check Werewolf Therapeutics Inc (HOWL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Werewolf Therapeutics Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Werewolf Therapeutics Inc across 7 annual periods. For the full cash flow conversion analysis, see Werewolf Therapeutics Inc cash conversion from operations.
Annual Financial Flexibility Index for Werewolf Therapeutics Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Werewolf Therapeutics Inc. Explore how well can Werewolf Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.35x | $-60.29 Million | $-60.29 Million | $44.59 Million | ▼ -29.4% |
| 2024 | -1.04x | $-55.93 Million | $-56.19 Million | $53.54 Million | ▼ -108.2% |
| 2023 | -0.50x | $-31.84 Million | $-32.61 Million | $63.46 Million | ▲ +48.6% |
| 2022 | -0.98x | $-36.98 Million | $-40.60 Million | $37.91 Million | ▲ +39.1% |
| 2021 | -1.60x | $-42.38 Million | $-42.88 Million | $26.46 Million | ▲ +36.4% |
| 2020 | -2.52x | $-18.06 Million | $-18.62 Million | $7.18 Million | ▼ -223.1% |
| 2019 | -0.78x | $-9.28 Million | $-9.54 Million | $11.91 Million | — |